Resultats globals: 7 registres trobats en 0.02 segons.
Articles, 6 registres trobats
Documents de recerca, 1 registres trobats
Articles 6 registres trobats  
1.
18 p, 1.4 MB Experimental Models for Aging and their Potential for Novel Drug Discovery / Folch, Jaume (Universitat Rovira i Virgili. Facultat de Medicina i Ciències de la Salut) ; Busquets, Oriol (Universitat Rovira i Virgili. Facultat de Medicina i Ciències de la Salut) ; Ettcheto, Miren (Universitat Rovira i Virgili. Facultat de Medicina i Ciències de la Salut) ; Sánchez-López, Elena (Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.) ; Pallàs, Mercè (Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.) ; Beas-Zarate, Carlos (Departamento de Biologia Celulary Molecular, C.U.C.B.A., Universidad de Guadalajara and Division de Neurociencias, Sierra Mojada 800, Col. Independencia, Guadalajara, Jalisco 44340, Mexico.) ; Marin, Miguel (Centro de Biotecnologia. Universidad Nacional de Loja, Av. Pío Jaramillo Alvarado y Reinaldo Espinosa, La Argelia. Loja, Ecuador.) ; Casadesus, Gemma (Department of Biological Sciences, Kent State University, Kent, OH, United States.) ; Olloquequi, Jordi (Instituto de Ciencias Biomedicas, Facultad de Ciencias de la Salud, Universidad Autonoma de Chile, Talca, Chile.) ; Auladell, Carme (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Camins, Antoni (Universitat de Barcelona. Departament de Farmacologia, Toxicologia i Química Terapèutica)
An interesting area of scientific research is the development of potential antiaging drugs. In order to pursue this goal, it is necessary to gather the specific knowledge about the adequate preclinical models that are available to evaluate the beneficial effects of new potential drugs. [...]
2018 - 10.2174/1570159X15666170707155345
Current neuropharmacology, Vol. 16 (december 2018) , p. 1466-1483  
2.
41 p, 2.4 MB Autophagy modulators : mechanistic aspects and drug delivery systems / Tavakol, Shima (Iran University of Medical Sciences. Cellular and Molecular Research Center) ; Ashrafizadeh, Milad (University of Tabriz. Department of basic science) ; Deng, Shuo (National University of Singapore. Department of Physiology) ; Azarian, Maryam (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Abdoli, Asghar (Pasteur Institute of Iran. Department of Hepatitis and AIDS) ; Motavaf, Mahsa (Tarbiat Modares University. Department of Molecular Genetics) ; Poormoghadam, Delaram (Islamic Azad University. Department of Medical Nanotechnology) ; Khanbabaei, Hashem (Ahvaz Jundishapur University of Medical Sciences. Medical Physics Departmen) ; Ghasemipour Afshar, Elham (Kerman University of Medical Sciences. Neuroscience Research Center) ; Mandegary, Ali (Kerman University of Medical Sciences. Neuroscience Research Center) ; Pardakhty, Abbas (Kerman University of Medical Sciences. Neuroscience Research Center) ; Yap, Celestial T. (National University of Singapore. Department of Physiology) ; Mohammadinejad, Reza (Kerman University of Medical Sciences. Pharmaceutics Research Center) ; Prem Kumar, Alan (Cancer Science Institute of Singapore) ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
Autophagy modulation is considered to be a promising programmed cell death mechanism to prevent and cure a great number of disorders and diseases. The crucial step in designing an effective therapeutic approach is to understand the correct and accurate causes of diseases and to understand whether autophagy plays a cytoprotective or cytotoxic/cytostatic role in the progression and prevention of disease. [...]
2019 - 10.3390/biom9100530
Biomolecules, Vol. 9, issue 10 (Sep. 2019) , art. 530  
3.
16 p, 2.6 MB Oncogenic p95HER2/611CTF primes human breast epithelial cells for metabolic stress-induced down-regulation of FLIP and activation of TRAIL-R/Caspase-8-dependent apoptosis / Martín-Pérez, Rosa (Lab of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium) ; Yerbes, Rosario (Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, Sevilla, Spain) ; Mora-Molina, Rocío (Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, Sevilla, Spain) ; Cano-González, Ana (Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, Sevilla, Spain) ; Arribas, Joaquín (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Mazzone, Massimiliano (Lab of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium) ; López-Rivas, Abelardo (Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Carlos III Health Institute, Madrid, Spain) ; Palacios, Carmen (Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, Sevilla, Spain)
Oncogenic transformation triggers reprogramming of cell metabolism, as part of the tumorigenic process. However, metabolic reprogramming may also increase the sensitivity of transformed cells to microenvironmental stress, at the early stages of tumor development. [...]
2017 - 10.18632/oncotarget.21458
Oncotarget, Vol. 8 (october 2017) , p. 93688-93703  
4.
7 p, 15.8 MB Study of breast cancer incidence in patients of lymphangioleiomyomatosis / Nuñez, Olivier (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Román, Antonio (Román Broto) (Hospital Universitari Vall d'Hebron) ; Johnson, Simon R. (National Centre for Lymphangioleiomyomatosis, Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, UK Division of Respiratory Medicine and Respiratory Research Unit, University of Nottingham) ; Inoue, Yoshikazu (National Hospital Organization Kinki-Chuo Chest Medical Center) ; Hirose, Masaki (National Hospital Organization Kinki-Chuo Chest Medical Center) ; Casanova, Álvaro (Department of Pneumology, Henares Hospital) ; de Garibay, Gorka Ruiz (ProCURE, Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO) Institute for Biomedical Research (IDIBELL)) ; Herranz-Ors, C. (Institut d'Investigació Biomèdica de Bellvitge) ; Bueno-Moreno, Gema (MD Anderson International Foundation) ; Boni, Jacopo (ProCURE, Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO) for Biomedical Research (IDIBELL), Gran via 199, L'Hospitalet del Llobregat) ; Mateo, Francesca (Institut d'Investigació Biomèdica de Bellvitge) ; Petit Montserrat, Anna (Institut d'Investigació Biomèdica de Bellvitge) ; Climent, Fina (Institut d'Investigació Biomèdica de Bellvitge) ; Soler, Teresa (Institut d'Investigació Biomèdica de Bellvitge) ; Vidal, August (Institut d'Investigació Biomèdica de Bellvitge) ; Sánchez-Mut, José Vicente (Cancer Epigenetics and Biology Program, IDIBELL) ; Esteller, Manel (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; López, José Ignacio (Cruces University Hospital, BioCruces Research Institute, University of the Basque Country) ; García, Nadia (ProCURE, Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO)Institute for Biomedical Research (IDIBELL), Gran via 199) ; Gumà, Anna (Institut d'Investigació Biomèdica de Bellvitge) ; Ortega, Raúl (Institut d'Investigació Biomèdica de Bellvitge) ; Plà, María Jesús (Institut d'Investigació Biomèdica de Bellvitge) ; Campos, Miriam (Breast Cancer Functional Unit, Department of Medical Oncology, ICO, IDIBELL) ; Ansótegui, Emilio (Lung Transplant and Cystic Fibrosis Unit, Hospital Universitario y Politecnico La Fe) ; Molina-Molina, María (Consortium for Biomedical Research in Respiratory Diseases (CIBERES), 28029 Madrid, Spain) ; Valenzuela, Claudia (Department of Pneumology, Instituto de Investigación Sanitaria La Princesa) ; Ussetti, Piedad ($u Hospital Clínica Puerta del Hierro. Departmento de Neumología) ; Laporta, Rosalía ($u Hospital Clínica Puerta del Hierro. Departmento de Neumología) ; Ancochea, Julio (Department of Pneumology, Instituto de Investigación Sanitaria La Princesa, Hospital La Princesa) ; Xaubet, Antoni (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Pollán, Marina (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Pujana, Miguel Angel (Institut d'Investigació Biomèdica de Bellvitge) ; Universitat Autònoma de Barcelona. Departament de Medicina
The online version of this article (doi:10. 1007/s10549-016-3737-8) contains supplementary material, which is available to authorized users.
2016 - 10.1007/s10549-016-3737-8
Breast Cancer Research and Treatment, Vol. 156 (march 2016) , p. 195-201  
5.
7 p, 1.3 MB Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated / Cabrera López, Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Bullich Vilanova, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Martí, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Català, Violeta (Institut d'Investigació Biomèdica Sant Pau) ; Ballarín Castan, José Aurelio (Institut d'Investigació Biomèdica Sant Pau) ; Bissler, John J. (Pediatric Nephrology Department, Le Bonheur Children's Hospital, Memphis, TN USA) ; Harris, Peter C. (Department of Biochemistry and Molecular Biology, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN USA) ; Ars Criach, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Mutations in TSC1 or TSC2 cause the tuberous sclerosis complex (TSC), while mutations in PKD1 or PKD2 cause autosomal dominant polycystic kidney disease (ADPKD). PKD1 lays immediately adjacent to TSC2 and deletions involving both genes, the PKD1/TSC2 contiguous gene syndrome (CGS), are characterized by severe ADPKD, plus TSC. [...]
2015 - 10.1186/s12881-015-0185-y
BMC Medical Genetics, Vol. 16 (june 2015)  
6.
6 p, 646.3 KB Internal translation of the connexin 43 transcript / Salat-Canela, Clàudia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sesé, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Peula, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Aasen, Trond (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Connexin 43 (Cx43), the most widely expressed gap junction protein, is associated with a number of physiological and pathological conditions. Many functions of Cx43 have been shown to be independent of gap junction formation and only require the expression of Cx43 C-terminal fragments. [...]
2014 - 10.1186/1478-811X-12-31
Cell Communication and Signaling : CCS, Vol. 12 (may 2014) , p. 31  

Documents de recerca 1 registres trobats  
1.
1 p, 1.2 MB The mammalian target of rapamycin : a cell key molulator of ageing / Viñals González, Xavier ; Genescà, A., (Anna), dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2013
Grau en Ciències Biomèdiques [832]  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.